A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.
Medicine by Design supports coronavirus research through contribution to Toronto COVID-19 Action Fund
Thirty-one research projects at U of T and its affiliated hospitals selected for funding to contribute to the global fight against the novel coronavirus.
Genome editing just got more versatile thanks to a new technology developed by Medicine by Design-funded investigators at U of T
Scientists can now edit multiple sites in the genome at the same time to learn how different DNA stretches co-operate in health and disease.
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
Medicine by Design-Funded Investigators Win Inaugural Canada-UK Funding to Develop AI Microrobots for Brain Surgery and Cell Manipulation
Tiny artificial intelligence (AI)-controlled robots could in the future be tasked with finding and capturing rare stem cells from brain tissue for therapy. While this type of microsurgery can take years to develop, Cindi Morshead and Aaron Wheeler have received a funding boost to make it happen.
Medicine by Design Executive Director Michael Sefton elected to the U.S. National Academy of Engineering
U of T professor recognized for his accomplishments in tissue engineering
'Your research will have a transformational impact on how we treat many common diseases, such as stroke, diabetes and liver failure, creating better health outcomes for all Canadians,' Bains tells annual symposium
'We think we can really accelerate the field and its capacity to improve lives'
Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investment
Projects to advance stem cell and gene therapy, enhance understanding of how the body repairs itself, and generate new technologies that will propel the field for decades
A new platform brings together genome editing with magnetic cell sorting to reveal new drug targets for cancer and regenerative medicine
Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only
Toronto investigators part of international team receiving $4-million (U.S.) award from Chan Zuckerberg Initiative
The project, part of the Human Cell Atlas, seeks to build a more complete map of the human liver and is a “direct extension” of the work the Toronto team has already done with support from Medicine by Design
Professor Shulamit Levenberg will serve as Medicine by Design’s first Scholar in Residence from July 15 to August 15, 2019.
International workshop tackles key policy questions around the adoption of regenerative medicine therapies
More than 40 academics, clinicians, policy-makers and industry leaders from Canada and the U.K. participated in the Challenges in the Adoption of Regenerative Medicine Therapies (CHART) workshop on June 24 and 25, 2019.
The competition was the culmination of Medicine by Design’s “Pitching Science” workshop, a six-week long program for graduate students, post-doctoral fellows and research associates